Related Experiment Videos
Rationale for therapy of allergic disorders
Pediatric Clinics of North America
|February 1, 1975
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.
The Journal of asthma : official journal of the Association for the Care of Asthma·2007
Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2000
Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.
Clinical therapeutics·2000
No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.
Pediatric clinics of North America·2026
Telemedicine and Access to Pediatric Dermatology Care.
Pediatric clinics of North America·2026
Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.
Pediatric clinics of North America·2026
Medical Photography's Power to Change Medical Care.
Pediatric clinics of North America·2026
Insurance Hurdles for Laser Authorization in Pediatric Patients.
Pediatric clinics of North America·2026
Controversies in Increasing the Pipeline for Pediatric Dermatology.
Pediatric clinics of North America·2026
Exploring the potential benefits of allergen immunotherapy beyond respiratory allergy.
Expert opinion on biological therapy·2026
Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling.
Journal of translational autoimmunity·2026
Bronchoalveolar Lavage Fluid α Amylase Level a Promising Biomarker of Aspiration Syndrome: A Pilot Study.
Infection and drug resistance·2026